Fine Foods & Pharmaceuticals NTM SpA
MIL:FF

Watchlist Manager
Fine Foods & Pharmaceuticals NTM SpA Logo
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Watchlist
Price: 7.44 EUR 0.81%
Market Cap: 182.2m EUR
Have any thoughts about
Fine Foods & Pharmaceuticals NTM SpA?
Write Note
Section:
 

Relative Value

The Relative Value of one FF stock under the Base Case scenario is 23.4 EUR. Compared to the current market price of 7.44 EUR, Fine Foods & Pharmaceuticals NTM SpA is Undervalued by 68%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FF Relative Value
Base Case
23.4 EUR
Undervaluation 68%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
98
vs Industry
85
Median 3Y
0.7
Median 5Y
1
Industry
4.1
Forward
0.7
More Details
24.1
P/E
P/E
Price to Earnings
24.1
vs History
33
vs Industry
Median 3Y
-24.3
Median 5Y
-16.3
Industry
32.7
Forward
20.7
More Details
4.4
P/OCF
P/OCF
Price to OCF
4.4
vs History
74
vs Industry
39
Median 3Y
5.3
Median 5Y
10.9
Industry
22.1
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
5
Industry
33.6
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
76
vs Industry
56
Median 3Y
1.5
Median 5Y
1.6
Industry
2.6
More Details
0.6
EV/S
EV/S
Enterprise Value to Sales
0.6
vs History
98
vs Industry
84
Median 3Y
0.8
Median 5Y
0.8
Industry
3.9
Forward
0.8
More Details
1.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.8
vs History
98
vs Industry
74
Median 3Y
2.6
Median 5Y
3
Industry
8.6
More Details
6.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6.1
vs History
98
vs Industry
42
Median 3Y
9.4
Median 5Y
9.4
Industry
18.5
Forward
6.2
More Details
12
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12
vs History
90
vs Industry
15
Median 3Y
29.7
Median 5Y
23.4
Industry
23.7
Forward
12.8
More Details
4.9
EV/OCF
EV/OCF
Enterprise Value to OCF
4.9
vs History
74
vs Industry
39
Median 3Y
5.9
Median 5Y
8.6
Industry
21.4
More Details
17.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
17.6
vs History
23
vs Industry
Median 3Y
-9.8
Median 5Y
-9.3
Industry
28.8
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
61
vs Industry
64
Median 3Y
1.1
Median 5Y
1.2
Industry
2.4
More Details

Multiples Across Competitors

FF Competitors Multiples
Fine Foods & Pharmaceuticals NTM SpA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
182.1m EUR 0.5 24.1 6.1 12
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 455.6 4 876 1 538.7 3 279.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
202.3B USD 4.8 33 21.4 30.6
US
Danaher Corp
NYSE:DHR
166.6B USD 7.8 42.8 26.9 40.4
KR
Samsung Biologics Co Ltd
KRX:207940
66.5T KRW 15.2 63.2 34.2 49.2
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.8B USD 6 30.1 22.4 26.1
US
IQVIA Holdings Inc
NYSE:IQV
36.3B USD 2.4 25.8 14.2 21.7
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD 7.2 34 24.3 27.2
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.4 48.3 32.4 40.7
CN
WuXi AppTec Co Ltd
SSE:603259
163.2B CNY 4.2 20.2 14.7 14.7

See Also

Summary
FF intrinsic value, competitors valuation, and company profile.
DCF Valuation
FF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FF stock valuation using valuation multiples.
Wall Street Estimates
FF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.